nodes	percent_of_prediction	percent_of_DWPC	metapath
Paramethadione—CYP2C9—urine—polycystic ovary syndrome	0.0238	0.146	CbGeAlD
Paramethadione—CYP2E1—urine—polycystic ovary syndrome	0.0225	0.138	CbGeAlD
Paramethadione—CYP3A4—urine—polycystic ovary syndrome	0.0181	0.111	CbGeAlD
Paramethadione—CACNA1H—uterus—polycystic ovary syndrome	0.014	0.0861	CbGeAlD
Paramethadione—CACNA1H—pituitary gland—polycystic ovary syndrome	0.0138	0.0846	CbGeAlD
Paramethadione—CACNA1H—adrenal gland—polycystic ovary syndrome	0.0123	0.0756	CbGeAlD
Paramethadione—CACNA1H—female gonad—polycystic ovary syndrome	0.0115	0.0705	CbGeAlD
Paramethadione—CACNA1H—endocrine gland—polycystic ovary syndrome	0.0107	0.0655	CbGeAlD
Paramethadione—CYP2C8—endometrium—polycystic ovary syndrome	0.00633	0.0388	CbGeAlD
Paramethadione—CYP2C8—pituitary gland—polycystic ovary syndrome	0.00573	0.0351	CbGeAlD
Paramethadione—CYP2C8—vagina—polycystic ovary syndrome	0.00474	0.0291	CbGeAlD
Paramethadione—CYP2C8—endocrine gland—polycystic ovary syndrome	0.00444	0.0272	CbGeAlD
Paramethadione—CYP2E1—adrenal gland—polycystic ovary syndrome	0.00431	0.0264	CbGeAlD
Paramethadione—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00394	0.0242	CbGeAlD
Paramethadione—CYP2E1—endocrine gland—polycystic ovary syndrome	0.00374	0.0229	CbGeAlD
Paramethadione—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00301	0.0184	CbGeAlD
Paramethadione—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00167	0.002	CbGpPWpGaD
Paramethadione—CYP2C8—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.00167	0.00199	CbGpPWpGaD
Paramethadione—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.00166	0.00198	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—AKT2—polycystic ovary syndrome	0.00165	0.00197	CbGpPWpGaD
Paramethadione—CYP2E1—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00161	0.00193	CbGpPWpGaD
Paramethadione—CYP2E1—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00161	0.00193	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.0016	0.00192	CbGpPWpGaD
Paramethadione—CYP2E1—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.00159	0.0019	CbGpPWpGaD
Paramethadione—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.00154	0.00184	CbGpPWpGaD
Paramethadione—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00151	0.00181	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—VEGFA—polycystic ovary syndrome	0.00151	0.00181	CbGpPWpGaD
Paramethadione—CYP2C8—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.0015	0.00179	CbGpPWpGaD
Paramethadione—CYP2C8—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.00148	0.00177	CbGpPWpGaD
Paramethadione—CYP2C9—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.00148	0.00176	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—LEP—polycystic ovary syndrome	0.00147	0.00176	CbGpPWpGaD
Paramethadione—CYP2E1—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.00144	0.00172	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—LEP—polycystic ovary syndrome	0.00143	0.00171	CbGpPWpGaD
Paramethadione—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00141	0.00168	CbGpPWpGaD
Paramethadione—CYP2C8—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.0014	0.00167	CbGpPWpGaD
Paramethadione—CYP2C8—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00139	0.00166	CbGpPWpGaD
Paramethadione—CYP2C9—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00138	0.00164	CbGpPWpGaD
Paramethadione—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.00137	0.00164	CbGpPWpGaD
Paramethadione—CYP2C8—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.00137	0.00164	CbGpPWpGaD
Paramethadione—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.00137	0.00164	CbGpPWpGaD
Paramethadione—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00136	0.00163	CbGpPWpGaD
Paramethadione—CYP2C9—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.00136	0.00162	CbGpPWpGaD
Paramethadione—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00136	0.00162	CbGpPWpGaD
Paramethadione—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.00132	0.00158	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00131	0.00156	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—PPARG—polycystic ovary syndrome	0.00128	0.00153	CbGpPWpGaD
Paramethadione—CYP2E1—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.00128	0.00152	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00127	0.00152	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00127	0.00152	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—INS—polycystic ovary syndrome	0.00126	0.00151	CbGpPWpGaD
Paramethadione—CYP2E1—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.00126	0.0015	CbGpPWpGaD
Paramethadione—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.00125	0.0015	CbGpPWpGaD
Paramethadione—CYP2C8—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.00125	0.00149	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—PPARG—polycystic ovary syndrome	0.00124	0.00149	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—INS—polycystic ovary syndrome	0.00122	0.00146	CbGpPWpGaD
Paramethadione—CYP2C9—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00122	0.00146	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—AKT2—polycystic ovary syndrome	0.00122	0.00146	CbGpPWpGaD
Paramethadione—CYP2C9—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.0012	0.00144	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—AKT2—polycystic ovary syndrome	0.00118	0.00141	CbGpPWpGaD
Paramethadione—CYP2C9—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00114	0.00136	CbGpPWpGaD
Paramethadione—CYP2C9—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00113	0.00135	CbGpPWpGaD
Paramethadione—CYP2C9—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.00112	0.00134	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—VEGFA—polycystic ovary syndrome	0.00112	0.00133	CbGpPWpGaD
Paramethadione—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00111	0.00133	CbGpPWpGaD
Paramethadione—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00111	0.00132	CbGpPWpGaD
Paramethadione—CYP2C8—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.0011	0.00132	CbGpPWpGaD
Paramethadione—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.00109	0.00131	CbGpPWpGaD
Paramethadione—CYP2C8—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.00109	0.0013	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—VEGFA—polycystic ovary syndrome	0.00108	0.00129	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—VEGFA—polycystic ovary syndrome	0.00108	0.00129	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00106	0.00127	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—IL6—polycystic ovary syndrome	0.00105	0.00125	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00103	0.00123	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00103	0.00123	CbGpPWpGaD
Paramethadione—CYP2E1—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.00103	0.00123	CbGpPWpGaD
Paramethadione—CYP2C9—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.00101	0.00121	CbGpPWpGaD
Paramethadione—CYP2E1—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.00101	0.00121	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00101	0.0012	CbGpPWpGaD
Paramethadione—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000973	0.00116	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000961	0.00115	CbGpPWpGaD
Paramethadione—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000908	0.00108	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000904	0.00108	CbGpPWpGaD
Paramethadione—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000898	0.00107	CbGpPWpGaD
Paramethadione—CYP2C9—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000897	0.00107	CbGpPWpGaD
Paramethadione—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000895	0.00107	CbGpPWpGaD
Paramethadione—CYP2C8—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000888	0.00106	CbGpPWpGaD
Paramethadione—CYP2C9—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000885	0.00106	CbGpPWpGaD
Paramethadione—CYP2C8—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000876	0.00105	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000865	0.00103	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000827	0.000988	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—SUOX—polycystic ovary syndrome	0.000827	0.000988	CbGpPWpGaD
Paramethadione—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000826	0.000986	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00082	0.00098	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000817	0.000977	CbGpPWpGaD
Paramethadione—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000804	0.000961	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000796	0.000951	CbGpPWpGaD
Paramethadione—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000793	0.000947	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000782	0.000935	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—NMNAT3—polycystic ovary syndrome	0.000781	0.000934	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—IL6—polycystic ovary syndrome	0.000772	0.000922	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000771	0.000921	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000769	0.000918	CbGpPWpGaD
Paramethadione—CYP2E1—Biological oxidations—POMC—polycystic ovary syndrome	0.000766	0.000916	CbGpPWpGaD
Paramethadione—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000749	0.000895	CbGpPWpGaD
Paramethadione—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000747	0.000893	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—IL6—polycystic ovary syndrome	0.000747	0.000893	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—IL6—polycystic ovary syndrome	0.000747	0.000892	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000745	0.000891	CbGpPWpGaD
Paramethadione—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000737	0.000881	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000729	0.000871	CbGpPWpGaD
Paramethadione—CYP2C9—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000723	0.000864	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—LPCAT2—polycystic ovary syndrome	0.000715	0.000854	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—SUOX—polycystic ovary syndrome	0.000715	0.000854	CbGpPWpGaD
Paramethadione—CYP2C9—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000713	0.000852	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000706	0.000843	CbGpPWpGaD
Paramethadione—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000669	0.0008	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000665	0.000795	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—ISYNA1—polycystic ovary syndrome	0.000664	0.000794	CbGpPWpGaD
Paramethadione—CYP2C8—Biological oxidations—POMC—polycystic ovary syndrome	0.000662	0.000791	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000654	0.000781	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—TEAD2—polycystic ovary syndrome	0.000654	0.000781	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000649	0.000776	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—NMNAT3—polycystic ovary syndrome	0.000636	0.00076	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000607	0.000725	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000606	0.000724	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000593	0.000708	CbGpPWpGaD
Paramethadione—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000592	0.000707	CbGpPWpGaD
Paramethadione—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000583	0.000697	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	0.000582	0.000695	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	0.000582	0.000695	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000575	0.000687	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000574	0.000686	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—TEAD2—polycystic ovary syndrome	0.000565	0.000675	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—AKR1C2—polycystic ovary syndrome	0.000565	0.000675	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—IL6—polycystic ovary syndrome	0.000551	0.000658	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000548	0.000654	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000543	0.000649	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	0.000541	0.000646	CbGpPWpGaD
Paramethadione—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	0.000539	0.000644	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000535	0.000639	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—IL6—polycystic ovary syndrome	0.000533	0.000637	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000529	0.000631	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000519	0.00062	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—STAR—polycystic ovary syndrome	0.000495	0.000592	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000493	0.00059	CbGpPWpGaD
Paramethadione—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000477	0.00057	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—PNPLA2—polycystic ovary syndrome	0.000473	0.000566	CbGpPWpGaD
Paramethadione—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.00047	0.000562	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000468	0.000559	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	0.00046	0.000549	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	0.00046	0.000549	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—SRD5A1—polycystic ovary syndrome	0.000449	0.000536	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000442	0.000528	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—HMMR—polycystic ovary syndrome	0.000441	0.000527	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000435	0.00052	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—STAR—polycystic ovary syndrome	0.000428	0.000512	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000423	0.000506	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000421	0.000503	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000419	0.000501	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	0.000385	0.00046	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—LHB—polycystic ovary syndrome	0.000384	0.000459	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000384	0.000458	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000384	0.000458	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—HMMR—polycystic ovary syndrome	0.000382	0.000456	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000375	0.000449	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	0.000365	0.000436	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—HSD3B1—polycystic ovary syndrome	0.000364	0.000435	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000364	0.000434	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.00036	0.00043	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000357	0.000426	CbGpPWpGaD
Paramethadione—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000356	0.000425	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	0.000348	0.000416	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000344	0.000412	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000341	0.000408	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000335	0.0004	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	0.000332	0.000397	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	0.000324	0.000388	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—RRM2—polycystic ovary syndrome	0.000324	0.000387	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	0.000314	0.000375	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—YAP1—polycystic ovary syndrome	0.000312	0.000373	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	0.000311	0.000371	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000303	0.000362	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000303	0.000362	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—NAMPT—polycystic ovary syndrome	0.0003	0.000359	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000296	0.000354	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	0.000296	0.000354	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000293	0.00035	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	0.000289	0.000346	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	0.00028	0.000335	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—AKR1C3—polycystic ovary syndrome	0.00028	0.000334	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000278	0.000332	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000276	0.000329	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	0.00027	0.000323	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	0.00027	0.000323	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	0.000264	0.000316	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	0.000259	0.00031	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000258	0.000308	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	0.000256	0.000306	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	0.000256	0.000306	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000254	0.000304	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000254	0.000304	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	0.000242	0.000289	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000241	0.000288	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—TH—polycystic ovary syndrome	0.000238	0.000285	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	0.000238	0.000285	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	0.000235	0.000281	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000232	0.000277	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.00023	0.000275	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	0.000228	0.000272	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	0.00022	0.000263	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000218	0.000261	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	0.000211	0.000252	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.00021	0.000251	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	0.000208	0.000249	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000207	0.000247	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—TH—polycystic ovary syndrome	0.000206	0.000246	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	0.000205	0.000245	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	0.0002	0.00024	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	0.000197	0.000235	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	0.000195	0.000233	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—GNAS—polycystic ovary syndrome	0.000195	0.000233	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	0.000194	0.000232	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	0.000188	0.000225	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—NCOR1—polycystic ovary syndrome	0.000185	0.000222	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	0.000178	0.000213	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000176	0.00021	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	0.000174	0.000208	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	0.000169	0.000202	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	0.000168	0.000201	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—TH—polycystic ovary syndrome	0.000168	0.0002	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—MTHFR—polycystic ovary syndrome	0.000164	0.000196	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	0.000163	0.000195	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	0.00016	0.000191	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	0.000155	0.000185	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	0.000153	0.000183	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	0.000152	0.000182	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	0.00015	0.00018	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	0.000145	0.000173	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	0.000142	0.000169	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	0.000139	0.000166	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	0.000138	0.000164	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	0.000137	0.000164	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—PPARG—polycystic ovary syndrome	0.000133	0.000159	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—POMC—polycystic ovary syndrome	0.000131	0.000157	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	0.00013	0.000156	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—INS—polycystic ovary syndrome	0.00013	0.000156	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	0.00013	0.000155	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	0.000128	0.000153	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	0.000124	0.000148	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	0.000115	0.000138	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	0.000115	0.000137	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	0.000113	0.000135	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—INS—polycystic ovary syndrome	0.000113	0.000135	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—TH—polycystic ovary syndrome	0.000111	0.000132	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	0.000108	0.000129	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	0.000101	0.000121	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	9.35e-05	0.000112	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	9.22e-05	0.00011	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—INS—polycystic ovary syndrome	9.17e-05	0.00011	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	9.03e-05	0.000108	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	8.6e-05	0.000103	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	8.15e-05	9.74e-05	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	7.6e-05	9.08e-05	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	6.16e-05	7.37e-05	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	6.08e-05	7.26e-05	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—INS—polycystic ovary syndrome	6.05e-05	7.22e-05	CbGpPWpGaD
